Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
McKinsey
Boehringer Ingelheim
Mallinckrodt
Express Scripts

Last Updated: March 23, 2023

Lemborexant - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for lemborexant and what is the scope of patent protection?

Lemborexant is the generic ingredient in one branded drug marketed by Eisai Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lemborexant has fifty-three patent family members in thirty-two countries.

One supplier is listed for this compound.

Summary for lemborexant
International Patents:53
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 38
Clinical Trials: 24
Patent Applications: 19
What excipients (inactive ingredients) are in lemborexant?lemborexant excipients list
DailyMed Link:lemborexant at DailyMed
Recent Clinical Trials for lemborexant

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Eisai Co., Ltd.Phase 2
Baylor College of MedicinePhase 3
University of California, San FranciscoPhase 4

See all lemborexant clinical trials

Pharmacology for lemborexant
Anatomical Therapeutic Chemical (ATC) Classes for lemborexant

US Patents and Regulatory Information for lemborexant

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eisai Inc DAYVIGO lemborexant TABLET;ORAL 212028-002 Apr 7, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Eisai Inc DAYVIGO lemborexant TABLET;ORAL 212028-001 Apr 7, 2020 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Eisai Inc DAYVIGO lemborexant TABLET;ORAL 212028-001 Apr 7, 2020 RX Yes No See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Eisai Inc DAYVIGO lemborexant TABLET;ORAL 212028-002 Apr 7, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Eisai Inc DAYVIGO lemborexant TABLET;ORAL 212028-002 Apr 7, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for lemborexant

Country Patent Number Title Estimated Expiration
European Patent Office 2626350 COMPOSÉ DE CYCLOPROPANE (CYCLOPROPANE COMPOUND) See Plans and Pricing
Tunisia 2013000119 CYCLOPROPANE COMPOUNDS See Plans and Pricing
Singapore 188585 CYCLOPROPANE COMPOUND See Plans and Pricing
Russian Federation 2017112308 КОМПОЗИЦИИ И СПОСОБЫ ДЛЯ ЛЕЧЕНИЯ БЕССОННИЦЫ See Plans and Pricing
Morocco 34609 COMPOSÉ DE CYCLOPROPANE See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
AstraZeneca
Baxter
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.